These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1293084)

  • 1. Comparative studies of isolated CD3: CD8, CD3: CD3, and monovalent CD3 binding on CD8+ T-cell activation: model of progressive T-cell receptor aggregation synergism.
    Wong JT; Bonventre JV; Dunn S; Colvin RB
    Hum Immunol; 1992 Nov; 35(3):200-8. PubMed ID: 1293084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of anti-CD3 monoclonal antibodies. Mediation of cytolysis by inter-T cell bridging.
    Wong JT; Eylath AA; Ghobrial I; Colvin RB
    Transplantation; 1990 Oct; 50(4):683-9. PubMed ID: 2145670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3 delta establishes a functional link between the T cell receptor and CD8.
    Doucey MA; Goffin L; Naeher D; Michielin O; Baumgärtner P; Guillaume P; Palmer E; Luescher IF
    J Biol Chem; 2003 Jan; 278(5):3257-64. PubMed ID: 12215456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
    Suthanthiran M
    J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor aggregation, but not dimerization, induces increased cytosolic calcium concentrations and reveals a lack of stable association between CD4 and the T cell receptor.
    Ratcliffe MJ; Coggeshall KM; Newell MK; Julius MH
    J Immunol; 1992 Mar; 148(6):1643-51. PubMed ID: 1531842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small number of anti-CD3 molecules on dendritic cells stimulate DNA synthesis in mouse T lymphocytes.
    Romani N; Inaba K; Puré E; Crowley M; Witmer-Pack M; Steinman RM
    J Exp Med; 1989 Mar; 169(3):1153-68. PubMed ID: 2522496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 4F2 antigen expressed on the MHC-negative target cells in the recognition of murine CD3+CD4-CD8- alpha beta (V alpha 4/V beta 2) T cells.
    Kubota H; Sato M; Ogawa Y; Iwai K; Hattori M; Yoshida T; Minato N
    Int Immunol; 1994 Sep; 6(9):1323-31. PubMed ID: 7819140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism in the activation of human CD8 T cells by cross-linking the T-cell receptor complex with the CD8 differentiation antigen.
    Emmrich F; Strittmatter U; Eichmann K
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8298-302. PubMed ID: 3095833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell activation by a bispecific anti-CD3/anti-major histocompatibility complex class I antibody.
    Roosnek E; Tunnacliffe A; Lanzavecchia A
    Eur J Immunol; 1990 Jun; 20(6):1393-6. PubMed ID: 2142461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
    Yang SY; Rhee S; Welte K; Dupont B
    J Immunol; 1988 Apr; 140(7):2115-20. PubMed ID: 3258328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies.
    Finck BK; Yung CM; Carteron NL; Wofsy D
    Clin Immunol Immunopathol; 1992 Dec; 65(3):234-41. PubMed ID: 1360341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preincubation with anti-CD4 influences activation of human T cells by subsequent co-cross-linking of CD4 with CD3.
    Tsygankov AY; Bröker BM; Guse AH; Meinke U; Roth E; Rossmann C; Emmrich F
    J Leukoc Biol; 1993 Nov; 54(5):430-8. PubMed ID: 8228621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4+ and CD8+ T lymphocytes.
    Campbell SB; Komata T; Kelso A
    Immunology; 2000 Mar; 99(3):394-401. PubMed ID: 10712669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological disintegration of lipid rafts decreases specific tetramer binding and disrupts the CD3 complex and CD8 heterodimer in human cytotoxic T lymphocytes.
    Uhlin M; Masucci MG; Levitsky V
    Scand J Immunol; 2003 Feb; 57(2):99-106. PubMed ID: 12588655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
    Kunicka JE; Platsoucas CD
    Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cells.
    De Lau WB; Boom SE; Heije K; Griffioen AW; Braakman E; Bolhuis RL; Tax WJ; Clevers H; Bast BJ
    J Immunol; 1992 Sep; 149(6):1840-6. PubMed ID: 1387662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte function-associated antigen 1 is an activation molecule for human T cells.
    Wacholtz MC; Patel SS; Lipsky PE
    J Exp Med; 1989 Aug; 170(2):431-48. PubMed ID: 2569026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.